Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug Read More February 18, 2026
Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making Read More February 18, 2026
Artificial intelligence translation in healthcare: an urgent call for evidence-informed policy frameworks Read More February 18, 2026
By the book or beyond? Lessons on implementation fidelity in remote patient monitoring within a hybrid hospital-at-home feasibility study Read More February 18, 2026